Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Hydra, Cubist Seek New Pain Drugs
|
Luke Timmerman |
10/19/09 |
Boston
|
|
Cadence, Aiming to Reduce Narcotics Use in Hospitals, Gears Up to Market IV Pain Reliever
|
Luke Timmerman |
07/07/09 |
San Diego
|
|
Cadence Applies for FDA Approval
|
Luke Timmerman |
05/14/09 |
San Diego
|
|
Alkermes, Swinging For the Fence, Touts New Anti-Addiction Drug
|
Luke Timmerman |
04/07/09 |
Boston
|
|
And Then There Were 3 at TorreyPines Therapeutics
|
Juha-Pekka Tikka |
04/01/09 |
San Diego
|
|
Pfizer’s VC Leader, Barbara Dalton, on Corporate Venture and Northwest Deal Hunting
|
Luke Timmerman |
03/17/09 |
Seattle
|
|
Cadence Drug Fails to Prevent Hospital Infections; Company Scraps Program
|
Luke Timmerman |
03/12/09 |
San Diego
|
|
Biogen Idec Aims to Regenerate Damaged Nerves, Crack Multi-Billion Dollar Market
|
Luke Timmerman |
03/11/09 |
Boston
|
|
Cadence Raises $86.6M in Private Stock Offering
|
Luke Timmerman |
02/17/09 |
San Diego
|
|
Stopping Migraines Before They Hurt: NeurAxon Pursues New Pain Drug
|
Luke Timmerman |
02/02/09 |
Boston
|
|
Cadence Turns Attention to Marketplace, as IV Pain Reliever Reaches Goals in Clinical Trials
|
Luke Timmerman |
12/18/08 |
San Diego
|
|
Cadence Shares Boom as IV Pain Reliever Reaches Goal in Study
|
Luke Timmerman |
12/17/08 |
San Diego
|
|
Seattle’s Pharma Godfather, Ben Shapiro, Sees Potential Here To Transform Medicine Despite Setbacks
|
Luke Timmerman |
11/17/08 |
Seattle
|
|
Impel NeuroPharma Develops Novel Delivery System to Get Drugs Into the Brain
|
Luke Timmerman |
08/29/08 |
Seattle
|
|
No Headache for NeurAxon: Company Closes $32 Million Financing Round
|
Robert Buderi |
08/20/07 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
